1883816-50-9

Met-RANTES (human) Chemical Structure
1883816-50-9

Chemical Structure

Met-RANTES (human)

Synonym(s): MSPYSSDTTPCCFAYIARPLPRAHIKEYFYTSGKCSN

  • CAS No.: 1883816-50-9
  • Formula:C355H543N97O101S6
  • Molecular Weight:7978.07

SMILES: O=C([C@@H](N)CCSC)N[C@H](C(N1[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N2[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N3[C@H](C(N[C@H](C(N4[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H]5CCCCN)=O)=O)CO)=O)[C@@H](C)O)=O)CC6=CC=C(O)C=C6)=O)CC7=CC=CC=C7)=O)CC8=CC=C(O)C=C8)=O)CCC(O)=O)=O)CCCCN)=O)[C@H](CC)C)=O)CC9=CNC=N9)=O)C)=O)CCCNC(N)=N)=O)CCC4)=O)CC(C)C)=O)CCC3)=O)CCCNC(N)=N)=O)C)=O)[C@H](CC)C)=O)CC%10=CC=C(O)C=C%10)=O)C)=O)CC%11=CC=CC=C%11)=O)CSSC[C@H](NC%12=O)C(N[C@H](C(N[C@H](C(N%13[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(O)=O)CO)=O)CCSC)=O)CCC(O)=O)=O)CC(C)C)=O)CO)=O)CC(N)=O)=O)[C@H](CC)C)=O)CC%14=CC=C(O)C=C%14)=O)CCC(O)=O)=O)CCCNC(N)=N)=O)C(C)C)=O)CC%15=CNC%16=CC=CC=C%15%16)=O)CCCCN)=O)CCCCN)=O)CCC(O)=O)=O)CCC%13)=O)CC(N)=O)=O)C)=O)=O)CSSC[C@H](NC5=O)C(N[C@H](C(N[C@H](C(N%17[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H]%12C(C)C)=O)CCC(N)=O)=O)CCCNC(N)=N)=O)CC(N)=O)=O)CCCCN)=O)CCCNC(N)=N)=O)[C@@H](C)O)=O)C(C)C)=O)CC%18=CC=CC=C%18)=O)C(C)C)=O)C(C)C)=O)C)=O)CCC%17)=O)CC(N)=O)=O)CO)=O)=O)CCC2)=O)[C@@H](C)O)=O)[C@@H](C)O)=O)CC(O)=O)=O)CO)=O)CO)=O)CC%19=CC=C(O)C=C%19)=O)CCC1)=O)CO

Biological Activity: Met-RANTES (human) is the antagonist for CCR1 and CCR5. Met-RANTES (human) inhibits chemokines human MIP-1α and MIP-1β with IC50 of 5 and 2 nM. Met-RANTES (human) reduces bone destruction and ameliorates rats adjuvant-induced arthritis (AIA)[1].

Cat. No. Product Name Purity Description Pricing
HY-P4191
Met-RANTES (human) Met-RANTES (human) is the antagonist for CCR1 and CCR5. Met-RANTES (human) inhibits chemokines human MIP-1α and MIP-1β with IC50 of 5 and 2 nM. Met-RANTES (human) reduces bone destruction and ameliorates rats adjuvant-induced arthritis (AIA).
Pricing 
Expand Hide
loading...
/
  • /
loading...
Size Price
Stock Quantity Availability Operate
/
In-stock
(Estimated to ship on )
(Estimated to ship TODAY)
Estimated to ship on
(Estimated to ship TODAY)

Amount:

USD 0.00

This product is a controlled substance and not for sale in your territory.

This product is not for sale in your territory.

Pricing 
Expand Hide
References